AI assistant
ATOMO DIAGNOSTICS LIMITED — Director's Dealing 2023
Apr 17, 2023
64440_rns_2023-04-17_8eb50c7f-158c-4931-b932-ebd76ab25195.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
| Introduced 30/09/01 Amended 01/01/11 | |
|---|---|
| Name of entity | Atomo Diagnostics Limited |
| ABN | 37 142 925 684 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Curt LaBelle |
|---|---|
| Date of last notice | 13 April 2022 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Direct | Direct | Indirect | Indirect |
|---|---|---|---|---|
| Nature of indirect interest | - | The Director is a controller | ||
| (including registered holder) | of | Global Health | ||
| Note: Provide details of the circumstances giving rise | Investment Fund, LLC. | |||
| to the relevant interest. | ||||
| Date of change | 11 | April 2023 | 11 April 2023 | |
| No. of securities held prior to change | A. | 240,000 | A. | 64,811,280 |
| B. | 240,000 | B. | 960,000 | |
| Class | A. | Fully paid ordinary | A. | Fully paid ordinary |
| shares | shares | |||
| B. | options to acquire | B. | options to acquire | |
| ordinaryshares | ordinaryshares | |||
| Number acquired | - | - | ||
| Number disposed | A. | - | A. | – |
| B. | 240,000 | B. | 960,000 | |
| Value/Consideration | - | - | ||
| Note: If consideration is non-cash, provide details | ||||
| and estimated valuation | ||||
| No. of securities held after change | A. | 240,000 Fully paid | A. | 64,811,280 Fully paid |
| ordinary shares | ordinary shares | |||
| B. | - | B. | - |
- See chapter 19 for defined terms.
01/01/2011
Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
Nature of change Expiry of unquoted options Expiry of unquoted options Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | n/a |
|---|---|
| Nature of interest | |
| Name of registered holder(if issued securities) | |
| Date of change | |
| No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changed | |
| Interest acquired | |
| Interest disposed | |
| Value/ConsiderationNote: If consideration is non-cash, provide detailsand an estimated valuation | |
| Interest after change |
Part 3 –[+] Closed period
| Part 3 –+Closed period | |
|---|---|
| Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required? | No. |
| If so, was prior written clearance provided to allow thetrade to proceed during this period? | |
| If prior written clearance was provided, on what date wasthis provided? |
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011